Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Quassia amara
Tropical American tree wood with intensely bitter quassinoids used in folk medicine for digestive conditions, malaria, and head lice treatment.
Quassia amara, a tropical American tree, yields intensely bitter wood containing quassinoids such as quassin, neoquassin, and simalikalactone D. It is traditionally used as a digestive bitter, antimalarial, and topical treatment for head lice, with modern evidence supporting its antiparasitic and anti-inflammatory properties.
Quassinoids activate bitter taste receptors (TAS2Rs) in the oral cavity and gut, stimulating gastric acid secretion and appetite via vagal reflexes. They inhibit Plasmodium falciparum growth by interfering with protein synthesis and blocking the parasite's digestive vacuole. Simalikalactone D exhibits anti-inflammatory activity through suppression of NF-κB and COX-2 pathways, while topical application disrupts louse nervous systems via GABA receptor antagonism.
Tropical American tree wood with intensely bitter quassinoids used in folk medicine for digestive conditions, malaria, and head lice treatment.
Quassia amara, a tropical American tree, yields intensely bitter wood containing quassinoids such as quassin, neoquassin, and simalikalactone D. It is traditionally used as a digestive bitter, antimalarial, and topical treatment for head lice, with modern evidence supporting its antiparasitic and anti-inflammatory properties.
Quassinoids activate bitter taste receptors (TAS2Rs) in the oral cavity and gut, stimulating gastric acid secretion and appetite via vagal reflexes. They inhibit Plasmodium falciparum growth by interfering with protein synthesis and blocking the parasite's digestive vacuole. Simalikalactone D exhibits anti-inflammatory activity through suppression of NF-κB and COX-2 pathways, while topical application disrupts louse nervous systems via GABA receptor antagonism.